CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $49,602,000 | +150.4% | 418,896 | +149.7% | 0.01% | +140.0% |
| Q4 2020 | $19,813,000 | -22.0% | 167,748 | -26.6% | 0.01% | -28.6% |
| Q3 2020 | $25,389,000 | +21.8% | 228,443 | +12.0% | 0.01% | 0.0% |
| Q2 2020 | $20,842,000 | +12.5% | 203,963 | +18.8% | 0.01% | -12.5% |
| Q1 2020 | $18,530,000 | +36.0% | 171,694 | +46.7% | 0.01% | +60.0% |
| Q4 2019 | $13,622,000 | +77.0% | 117,046 | +74.1% | 0.01% | +25.0% |
| Q3 2019 | $7,694,000 | +252.1% | 67,217 | +193.2% | 0.00% | +300.0% |
| Q2 2019 | $2,185,000 | -57.0% | 22,925 | -58.8% | 0.00% | -50.0% |
| Q1 2019 | $5,083,000 | +136.5% | 55,695 | +96.8% | 0.00% | +100.0% |
| Q4 2018 | $2,149,000 | -52.5% | 28,306 | -50.0% | 0.00% | -66.7% |
| Q3 2018 | $4,524,000 | +0.6% | 56,556 | +24.9% | 0.00% | +50.0% |
| Q2 2018 | $4,499,000 | +653.6% | 45,293 | +514.3% | 0.00% | – |
| Q1 2018 | $597,000 | – | 7,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |